Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

ABL Bio and Sanofi partner to develop antibody for Parkinson’s disease

Pharmaceutical-TechnologyJanuary 13, 2022

Tag: ABL Bio , ABL301 , antibody

PharmaSources Customer Service